EARNEST Partners
VASC

EARNEST Partners’s Vascular Solutions Inc VASC Stock Holding History

EARNEST Partners’s Portfolio VASC Stock Details VASC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,100
Closed -$62K – 1141
2016
Q4 		$62K Hold
1,100
– – ﹤0.01% 268
2016
Q3 		$53K Hold
1,100
– – ﹤0.01% 245
2016
Q2 		$46K Hold
1,100
– – ﹤0.01% 252
2016
Q1 		$36K Hold
1,100
– – ﹤0.01% 268
2015
Q4 		$38K Hold
1,100
– – ﹤0.01% 260
2015
Q3 		$36K Hold
1,100
– – ﹤0.01% 255
2015
Q2 		$38K Hold
1,100
– – ﹤0.01% 252
2015
Q1 		$33K Hold
1,100
– – ﹤0.01% 259
2014
Q4 		$30K Hold
1,100
– – ﹤0.01% 271
2014
Q3 		$27K Hold
1,100
– – ﹤0.01% 261
2014
Q2 		$24K Hold
1,100
– – ﹤0.01% 285
2014
Q1 		$29K Sell
1,100
-500
-31% -$12.4K ﹤0.01% 270
2013
Q4 		$37K Buy
+1,600
New +$31.4K ﹤0.01% 280

Other funds holding VASC

FPF
FNY Partners Fund New York $185M AUM 32.58% 1-Year Est. Return

EARNEST Partners's VASC Position: Q1 2017 in Review

EARNEST Partners sold out of Vascular Solutions Inc (VASC) in Q1 2017, closing a stake of 1,100 shares — an estimated $62K sold.

EARNEST Partners first reported a position in VASC in Q4 2013 and held it in 13 quarters. The position peaked at $62K in Q4 2016. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • EARNEST Partners reported no remaining Vascular Solutions Inc position as of Q1 2017 after selling out during the quarter.
  • EARNEST Partners sold 1,100 Vascular Solutions Inc shares in Q1 2017, an estimated $62K.
  • EARNEST Partners first reported a position in Vascular Solutions Inc in Q4 2013 and held it in 13 quarters.
  • EARNEST Partners's Vascular Solutions Inc position peaked at $62K in Q4 2016.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions Inc as of Q1 2017.

Based on EARNEST Partners's 13F filing for Q1 2017, filed 15 May 2017.